Our finding shows that skeletal muscle wasting in the MCT-treated PAH model is accompanied by an increase in circulating GDF11 levels and local catabolic markers (Fbx32, Trim63, Foxo1, and protease activity). Here, FBXO32 is linked to pulmonary arterial hypertension.